Mood Disorders Clinical Trial
— BEAMOfficial title:
Neurobehavioral Targets of Mindfulness in Youth at Risk for Mood Disorders
Mood lability is an important transdiagnostic problem that is associated with poor psychosocial function and suicidal thoughts, and is a predictor of mood disorder onset, especially in youth at familial risk. Thus, particularly in youth with a family history of mood disorder, an intervention to target mood lability during a key period of development could improve outcomes. This study will allow us to test neurobehavioral mechanisms of a mindfulness-based intervention to target mood lability in early adolescents at high risk for developing mood disorders. Through this randomized controlled trial, the investigators will better understand how and for whom mindfulness interventions work, which will lead to more targeted interventions to improve emotion regulation during this key developmental period.
Status | Recruiting |
Enrollment | 140 |
Est. completion date | February 28, 2027 |
Est. primary completion date | February 28, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years to 14 Years |
Eligibility | Inclusion Criteria: - Males and females between the ages of 11-14 years - Parent or full biological sibling with major depressive disorder and/or bipolar I/II disorder - Elevated mood lability, which is defined as >10 on the Children's Affective Lability Scale (averaging the child and parent score). Exclusion Criteria: - IQ<70 or significant learning disability (which will make it difficult to participate in study procedures) - Current or previous diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or autism spectrum disorder - Current diagnosis of major depressive disorder - Contraindications to scanning, including metal in the body (e.g. has braces or planning to get braces within the next 8 months) - Suicidal or homicidal ideation within the past month - Changed medications or medication doses (including psychotropic medications and/or hormonal contraceptives), or have started a new therapy, within the past two months. For each eligible youth, a parent (when possible, the parent with a mood disorder) will also be enrolled in the study, to provide a detailed account of family history. The only inclusion criterion for the parent participants is that they have an eligible child. |
Country | Name | City | State |
---|---|---|---|
United States | Western Psychiatric Hospital | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Institute of Mental Health (NIMH) |
United States,
Hafeman DM, Ostroff AN, Feldman J, Hickey MB, Phillips ML, Creswell D, Birmaher B, Goldstein TR. Mindfulness-based intervention to decrease mood lability in at-risk youth: Preliminary evidence for changes in resting state functional connectivity. J Affect Disord. 2020 Nov 1;276:23-29. doi: 10.1016/j.jad.2020.06.042. Epub 2020 Jul 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PCC-FPCN rsFC: Seed-based | During each visit, the investigators will collect 10 minutes of resting-state data (eyes open; 2 runs, 5 minutes each), using Framewise Integrated Real-time MRI Monitoring (FIRMM) to ensure high quality. Following preprocessing, the investigators will assess resting-state functional connectivity between the posterior cingulate cortex (PCC; 0,-62,24; 4mm radius) and the frontoparietal control network (FPCN). The investigators will use mixed models to assess changes over time in the MBI vs. HWI group. | PCC-FPCN rsFC will be assessed up to 3 months after completing the MBI/HWI group. | |
Primary | SART Accuracy | Participants will complete a Sustained Attention to Response Task (SART). In this task, numbers 1-9 will be sequentially displayed on the screen. Participants will be asked to press the space bar for every number except for "3". Overall target discrimination (d') will be assessed by calculating and z-transforming the "false alarm rate" (% omission errors, i.e. failing to press the space bar when indicated) and subtracting it from the z-transformed "hit rate" (% correct omissions, i.e. accurately not pressing the space bar to "3"). The investigators will use mixed models to assess changes over time in the MBI vs. HWI group. | SART accuracy will be assessed up to 3 months after completing the MBI/HWI group. | |
Primary | SART: Mind-wandering Awareness Probe | Participants will complete a Sustained Attention to Response Task (SART). In this task, numbers 1-9 will be sequentially displayed on the screen. Participants will be asked to press the space bar for every number except for "3". To assess mind-wandering awareness, following each block of 10, 14, 18, 22, or 26 trials, participants will be asked to rate on 5-point likert scales "Where was your attention focused just now?"; and "How aware were you of where your attention was?". Self-report probes will be classified as on-task (responses 1-2 on 5-point "on-task" scale); off-task aware (responses 3-5 on 5-point "on-task" scale + responses 1-2 on 5-point "aware" scale); or off-task unaware (responses 3-5 on 5-point "on-task" scale + responses 3-5 on 5-point "aware" scale). The investigators will use mixed models to assess changes over time in the MBI vs. HWI group. | Mind-wandering during the SART will be assessed up to 3 months after completing the MBI/HWI group. | |
Secondary | SART: Reaction Time Variability | Participants will complete a Sustained Attention to Response Task (SART). In this task, numbers 1-9 will be sequentially displayed on the screen. Participants will be asked to press the space bar for every number except for "3". Standard deviation of the RT will be calculated as an estimate of variability, a likely indicator of mind-wandering. | SART reaction time variability will be assessed before the MBI/HWI group. | |
Secondary | PCC-FPCN rsFC: Seed-based | During each visit, the investigators will collect 10 minutes of resting-state data (eyes open; 2 runs, 5 minutes each), using FIRMM to ensure high quality. Following preprocessing, the investigators will assess resting-state functional connectivity between the posterior cingulate cortex (PCC; 0,-62,24; 4mm radius) and the frontoparietal control network (FPCN). | The investigators will test specifically for early differences (prior to the MBI/HWI group to immediately following the MBI/HWI group) and assess whether these differences are sustained (immediately following the MBI/HWI group to 3 month follow-up). | |
Secondary | SART Accuracy | Participants will complete a Sustained Attention to Response Task (SART). In this task, numbers 1-9 will be sequentially displayed on the screen. Participants will be asked to press the space bar for every number except for "3". Overall target discrimination (d') will be assessed by calculating and z-transforming the "false alarm rate" (% omission errors, i.e. failing to press the space bar when indicated) and subtracting it from the z-transformed "hit rate" (% correct omissions, i.e. accurately not pressing the space bar to "3"). | The investigators will test specifically for early differences (prior to the MBI/HWI group to immediately following the MBI/HWI group) and assess whether these differences are sustained (immediately following the MBI/HWI group to 3 month follow-up). | |
Secondary | SART: Mind-wandering Awareness Probe | Participants will complete a Sustained Attention to Response Task (SART). In this task, numbers 1-9 will be sequentially displayed on the screen. Participants will be asked to press the space bar for every number except for "3". To assess mind-wandering awareness, following each block of 10, 14, 18, 22, or 26 trials, participants will be asked to rate on 5-point likert scales "Where was your attention focused just now?"; and "How aware were you of where your attention was?". Self-report probes will be classified as on-task (responses 1-2 on 5-point "on-task" scale); off-task aware (responses 3-5 on 5-point "on-task" scale + responses 1-2 on 5-point "aware" scale); or off-task unaware (responses 3-5 on 5-point "on-task" scale + responses 3-5 on 5-point "aware" scale). | The investigators will test specifically for early differences (prior to the MBI/HWI group to immediately following the MBI/HWI group) and assess whether these differences are sustained (immediately following the MBI/HWI group to 3 month follow-up). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05078450 -
Mood Lifters Online for Graduate Students and Young Professionals
|
N/A | |
Not yet recruiting |
NCT04551027 -
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness
|
N/A | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Active, not recruiting |
NCT02542475 -
Low Field Magnetic Stimulation: Open Label Study.
|
Phase 1/Phase 2 | |
Completed |
NCT00916552 -
Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
|
Phase 2 | |
Completed |
NCT00202514 -
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
|
Phase 2/Phase 3 | |
Completed |
NCT00217932 -
Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings
|
Phase 2 | |
Completed |
NCT00006517 -
Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)
|
N/A | |
Terminated |
NCT03898843 -
Assisted Animal Therapy: ReAnimal
|
N/A | |
Active, not recruiting |
NCT04358900 -
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
|
||
Recruiting |
NCT06360562 -
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
|
N/A | |
Completed |
NCT05745103 -
Optimizing Behavioral Healthcare Delivery Through Technology
|
N/A | |
Suspended |
NCT03715400 -
Mobile Virtual Positive Experiences for Anhedonia
|
N/A | |
Enrolling by invitation |
NCT03736538 -
Nitrous Oxide- Suicidal Ideation
|
Phase 1 | |
Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
Completed |
NCT02566980 -
Biological Triggers of Depression in Pregnancy
|
||
Completed |
NCT03743844 -
Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity
|
N/A | |
Completed |
NCT05211063 -
Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders
|
N/A | |
Completed |
NCT02263872 -
Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
|
Phase 4 |